DEGENERATION OF UTERINE LEIOMYOMA

DEGENERATION OF UTERINE LEIOMYOMA was reported 21 times

DEGENERATION OF UTERINE LEIOMYOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Guanylate Cyclase-C Agonist [EPC] 1 0.0005
1 Tissue-nonspecific Alkaline Phosphatase [EPC] 1 0.0001
2 Gonadotropin Releasing Hormone Receptor Antagonist [EPC] 2 0.0001
3 Vitamin D3 Analog [EPC] 1 0.0000
4 Copper-containing Intrauterine Device [EPC] 1 0.0000
5 Estrogen [EPC] 2 0.0000
6 Fluoroquinolone Antibacterial [EPC] 1 0.0000
7 Vitamin C [EPC] 3 0.0000
8 Progestin [EPC] 2 0.0000
9 Vitamin D [EPC] 2 0.0000
10 Azole Antifungal [EPC] 1 0.0000
11 Vitamin B12 [EPC] 2 0.0000
12 RANK Ligand Inhibitor [EPC] 1 0.0000
13 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
14 GLP-1 Receptor Agonist [EPC] 1 0.0000
15 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000
16 Benzodiazepine [EPC] 1 0.0000